| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/31/2006 | US7129250 Neuroprotective and anti-proliferative compounds |
| 10/31/2006 | US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 10/31/2006 | US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride |
| 10/31/2006 | CA2383599C Methods, kits and compositions for using pyrrole derivatives |
| 10/31/2006 | CA2262796C 4-substituted beta-carbolines as immunomodulators |
| 10/31/2006 | CA2247419C Oxazole derivatives, their production and use |
| 10/26/2006 | WO2006113875A2 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 10/26/2006 | WO2006112828A1 Azaindole derivatives as inhibitors of p38 kinase |
| 10/26/2006 | WO2006112666A1 Pyridine derivatives, methods of their preparations, and pharmaceutical compositions containing the same |
| 10/26/2006 | WO2006112549A1 Fused heterocyclic compound |
| 10/26/2006 | WO2006112479A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | WO2006112331A1 Novel condensed pyrrole derivative |
| 10/26/2006 | WO2006111511A1 Hexarylene and pentarylene tetracarboxylic acid diimides |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2006075012A3 Pyrrolodihydroisoquinolines as antiproliferative agents |
| 10/26/2006 | WO2006065448A3 Topoisomerase inhibitors and prodrugs |
| 10/26/2006 | WO2006028962A3 1-alkoxy 1h-imidazo ring systems and methods |
| 10/26/2006 | WO2006021399A3 Azabicyclononene derivatives as renin inhibitors |
| 10/26/2006 | WO2005087745A8 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 10/26/2006 | US20060241301 Urea derivatives and their use as tyrosinkinase inhibitors |
| 10/26/2006 | US20060241151 Pyrid-2-one derivatives and methods of use |
| 10/26/2006 | US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis |
| 10/26/2006 | US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient |
| 10/26/2006 | US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction |
| 10/26/2006 | US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation |
| 10/26/2006 | US20060241123 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/26/2006 | US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/26/2006 | US20060241112 Kinase inhibitors |
| 10/26/2006 | US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope |
| 10/26/2006 | US20060240452 Flourecent quinacridone derivatives |
| 10/26/2006 | US20060239936 Delivery of anti-migraine compounds through an inhalation route |
| 10/26/2006 | DE112004001116T5 Chinonverbindung und elektrophotographischer Photorezeptor und diese verwendendes elektrophotographisches Gerät Quinone compound and electrophotographic photoreceptor-use and this electrophotographic apparatus |
| 10/26/2006 | DE102005019181A1 New indene compound are peptide-deformylase inhibitors useful e.g. to treat or prevent diseases mediated by metalloproteinase activity and peptide-deformylase activity |
| 10/26/2006 | DE102005019094A1 New aza-heterocyclic compounds are tyrosine kinase inhibitor useful to prevent and/or treat cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
| 10/26/2006 | CA2610446A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | CA2605778A1 Fused heterocyclic compound |
| 10/26/2006 | CA2605075A1 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 10/26/2006 | CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism |
| 10/25/2006 | EP1714966A1 Naphthylidine derivative having hiv integrase inhibitory activity |
| 10/25/2006 | EP1714961A1 Indazole compound and pharmaceutical use thereof |
| 10/25/2006 | EP1713810A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
| 10/25/2006 | EP1713807A1 Vanilloid receptor ligands and their use in treatments |
| 10/25/2006 | EP1713806A1 Compounds and compositions as protein kinase inhibitors |
| 10/25/2006 | EP1713805A1 Kinase inhibitors |
| 10/25/2006 | EP1713804A1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 10/25/2006 | EP1713803A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 10/25/2006 | EP1713802A1 2,4-dioxopyrimidine-based mesoionic pigments |
| 10/25/2006 | EP1713778A1 Benzazepine derivatives as histamine h3 antagonists |
| 10/25/2006 | EP1713777A1 Method for producing terrylen-3,4:11,12-tetracarbon acid di-imids |
| 10/25/2006 | EP1713487A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| 10/25/2006 | EP1713484A2 Compounds and methods of use |
| 10/25/2006 | EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 10/25/2006 | EP1654262B1 7-azaindole derivatives as cox2 inhibitors |
| 10/25/2006 | EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 10/25/2006 | EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 10/25/2006 | EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
| 10/25/2006 | EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN |
| 10/25/2006 | EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/25/2006 | EP1287532A4 Method for producing ?18 f|fluoride ion |
| 10/25/2006 | EP1187613B9 Amide substituted imidazoquinolines |
| 10/25/2006 | CN1850823A Quinolone compound containing oximino, and its preparing method and use |
| 10/25/2006 | CN1281608C New azo-indolyl derivatives |
| 10/25/2006 | CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect |
| 10/25/2006 | CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
| 10/24/2006 | US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) |
| 10/24/2006 | US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 10/24/2006 | US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 10/24/2006 | US7125888 Tyrosine kinase inhibitors |
| 10/24/2006 | US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 10/24/2006 | US7125886 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
| 10/24/2006 | US7125885 2-substituted-9-trifluoromethyl-11-methyl-1,2,3,4,5,11-hexahydro-6H-pyrido(3,2-b)carbazole compounds as melanin-concentrating hormone receptor modulators for treatment of G-protein coupled receptor-mediated disorders such as eating disorders, obesity, anxiety disorders and mood disorders |
| 10/24/2006 | US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/24/2006 | CA2259031C Androgen receptor modulator compounds and methods |
| 10/24/2006 | CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 10/19/2006 | WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 10/19/2006 | WO2006109846A1 Triazole derivative and the use thereof |
| 10/19/2006 | WO2006109085A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | WO2006109084A1 Dna-pk inhibitors |
| 10/19/2006 | WO2006109081A1 Dna-pk inhibitors |
| 10/19/2006 | WO2006108712A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 10/19/2006 | WO2006108693A2 Process for preparing bicyclic compounds |
| 10/19/2006 | WO2006108689A2 Process for preparing bicyclic compounds |
| 10/19/2006 | WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | WO2006065601A8 Inhibitors of akt activity |
| 10/19/2006 | US20060235228 Novel intermediate for the preparation of therapeutically active imidazopyridines |
| 10/19/2006 | US20060235223 Variolin derivatives and their use as antitumor agents |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | US20060235044 Azabicyclononene derivatives |
| 10/19/2006 | US20060235043 Antiviral Pyrazolopyridine Compounds |
| 10/19/2006 | US20060235042 Substitued azaindoline intermediate for use in the manufacture of 5-substituted 7-azaindolines and 5-substituted 7-azaindoles; pharmaceutical intermediates |
| 10/19/2006 | US20060235031 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 10/19/2006 | US20060235029 Novel compounds |
| 10/19/2006 | US20060235019 Substituted quinazolinone compounds |
| 10/19/2006 | US20060235014 Inhibitors of p38 |
| 10/19/2006 | US20060235012 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 10/19/2006 | US20060235011 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine; depressive symptom, mania, anxiety, general anxiety disorder, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, Tourette's syndrome |
| 10/19/2006 | US20060234148 Pyrrole units to allow chemical and electrochemical polymerization and a perylene diimide unit to absorb light so that the perylene diimide film can be produced by crosslinking via pyrrole moieties upon irradiating visible light; electrical, electronical and optical devices such as photo diodes |